{"adverse_reactions":["Sincerus Florida, LLC. Advese reactions d"],"components":["Active, inactive f"],"effective_time":"20190515","id":"88ef2cc1-1856-9606-e053-2995a90a2e67","instructions_for_use":["Directions for use ds"],"openfda":{},"package_label_principal_display_panel":["NDC 72934- 1027-2 BRIMONIDINE TARTRATE USP 0.25% . Gel 30gm d"],"set_id":"88ef2cc1-1855-9606-e053-2995a90a2e67","spl_product_data_elements":["BRIMONIDINE TARTRATE 0.25% / POTASSIUM AZELOYL DIGLYCINATE 8% BRIMONIDINE TARTRATE 0.25% / POTASSIUM AZELOYL DIGLYCINATE 8% BRIMONIDINE TARTRATE BRIMONIDINE"],"version":"1"}